Cargando…
Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
Intrathecal immunoglobulin G (IgG) synthesis, cerebrospinal fluid (CSF) oligoclonal IgG bands and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease pathology. Both the specific targets and pathogenic effects of MS antibodies remain poorly characterized. We produced IgG1...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366134/ https://www.ncbi.nlm.nih.gov/pubmed/28340598 http://dx.doi.org/10.1186/s40478-017-0428-6 |
_version_ | 1782517535513509888 |
---|---|
author | Liu, Yiting Given, Katherine S. Harlow, Danielle E. Matschulat, Adeline M. Macklin, Wendy B. Bennett, Jeffrey L. Owens, Gregory P. |
author_facet | Liu, Yiting Given, Katherine S. Harlow, Danielle E. Matschulat, Adeline M. Macklin, Wendy B. Bennett, Jeffrey L. Owens, Gregory P. |
author_sort | Liu, Yiting |
collection | PubMed |
description | Intrathecal immunoglobulin G (IgG) synthesis, cerebrospinal fluid (CSF) oligoclonal IgG bands and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease pathology. Both the specific targets and pathogenic effects of MS antibodies remain poorly characterized. We produced IgG1 monoclonal recombinant antibodies (rAbs) from clonally-expanded plasmablasts recovered from MS patient CSF. Among these were a subset of myelin-specific MS rAbs. We examined their immunoreactivity to mouse organotypic cerebellar slices by live binding and evaluated tissue injury in the presence and absence of human complement. Demyelination, glial and neuronal viability, and complement pathway activation were assayed by immunofluorescence microscopy and compared to the effects of an aquaporin-4 water channel (AQP4)-specific rAb derived from a neuromyelitis optica (NMO) patient. MS myelin-specific rAbs bound to discrete surface domains on oligodendrocyte processes and myelinating axons. Myelin-specific MS rAbs initiated complement-dependent cytotoxicity to oligodendrocytes and induced rapid demyelination. Demyelination was accompanied by increased microglia activation; however, the morphology and survival of astrocytes, oligodendrocyte progenitors and neurons remained unaffected. In contrast, NMO AQP4-specific rAb initiated complement-dependent astrocyte damage, followed by sequential loss of oligodendrocytes, demyelination, microglia activation and neuronal death. Myelin-specific MS antibodies cause oligodendrocyte loss and demyelination in organotypic cerebellar slices, which are distinct from AQP4-targeted pathology, and display seminal features of active MS lesions. Myelin-specific antibodies may play an active role in MS lesion formation through complement-dependent mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0428-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5366134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53661342017-03-28 Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination Liu, Yiting Given, Katherine S. Harlow, Danielle E. Matschulat, Adeline M. Macklin, Wendy B. Bennett, Jeffrey L. Owens, Gregory P. Acta Neuropathol Commun Research Intrathecal immunoglobulin G (IgG) synthesis, cerebrospinal fluid (CSF) oligoclonal IgG bands and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease pathology. Both the specific targets and pathogenic effects of MS antibodies remain poorly characterized. We produced IgG1 monoclonal recombinant antibodies (rAbs) from clonally-expanded plasmablasts recovered from MS patient CSF. Among these were a subset of myelin-specific MS rAbs. We examined their immunoreactivity to mouse organotypic cerebellar slices by live binding and evaluated tissue injury in the presence and absence of human complement. Demyelination, glial and neuronal viability, and complement pathway activation were assayed by immunofluorescence microscopy and compared to the effects of an aquaporin-4 water channel (AQP4)-specific rAb derived from a neuromyelitis optica (NMO) patient. MS myelin-specific rAbs bound to discrete surface domains on oligodendrocyte processes and myelinating axons. Myelin-specific MS rAbs initiated complement-dependent cytotoxicity to oligodendrocytes and induced rapid demyelination. Demyelination was accompanied by increased microglia activation; however, the morphology and survival of astrocytes, oligodendrocyte progenitors and neurons remained unaffected. In contrast, NMO AQP4-specific rAb initiated complement-dependent astrocyte damage, followed by sequential loss of oligodendrocytes, demyelination, microglia activation and neuronal death. Myelin-specific MS antibodies cause oligodendrocyte loss and demyelination in organotypic cerebellar slices, which are distinct from AQP4-targeted pathology, and display seminal features of active MS lesions. Myelin-specific antibodies may play an active role in MS lesion formation through complement-dependent mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0428-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-24 /pmc/articles/PMC5366134/ /pubmed/28340598 http://dx.doi.org/10.1186/s40478-017-0428-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Liu, Yiting Given, Katherine S. Harlow, Danielle E. Matschulat, Adeline M. Macklin, Wendy B. Bennett, Jeffrey L. Owens, Gregory P. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
title | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
title_full | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
title_fullStr | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
title_full_unstemmed | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
title_short | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
title_sort | myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366134/ https://www.ncbi.nlm.nih.gov/pubmed/28340598 http://dx.doi.org/10.1186/s40478-017-0428-6 |
work_keys_str_mv | AT liuyiting myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination AT givenkatherines myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination AT harlowdaniellee myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination AT matschulatadelinem myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination AT macklinwendyb myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination AT bennettjeffreyl myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination AT owensgregoryp myelinspecificmultiplesclerosisantibodiescausecomplementdependentoligodendrocytelossanddemyelination |